Gene Query: UVSSA

Dataset Description Geneva Score
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 18.69
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 13.73
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 11.28
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 11.23
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 11.23
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 10.38
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 10.02
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 10.02
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.0
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.66
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 8.94
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 8.87
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.84
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 7.72
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 7.36
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 7.11
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 6.9
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.89
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.18
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.18
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.98
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.74
Transcriptome Profiling of Human Primary Monocytes 5.72
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.28
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.13
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 4.99
Transcriptome of Stabilin-1 siRNA transfected human monocytes 4.97
Transciptomic profiling of human fetal lung samples 4.92
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.82
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 4.61
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 4.57
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.5
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.48
The evolution of N6-methyladenosine in primates 4.47
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.4
METTL3 promotes translation in human cancer cells 4.37
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 4.34
Primary human trophoblast from term placenta 4.34
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.28
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.03
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.0
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.99
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.87
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.87
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.8
The human blood-nerve barrier transcriptome 3.79
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 3.78
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 3.78
Gene expression profile of human placenta from T. Cruzi infected mothers 3.77
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.75
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.72
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.7
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.66
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 3.59
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.58
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.57
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.56
Intrahepatic MAIT cell gene expression revealed by RNA-seq 3.55
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.54
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 3.49
IMP3 regulated gene expression in breast cancer cells 3.48
RNA-seq of tumor cells following angiopellosis extravasation 3.47
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.4
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.38
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.36
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.31
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.27
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.27
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.25
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 3.2
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.18
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.18
Pharmacologic inhibition of STAT5 in AML 3.1
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.07
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 3.07
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.05
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.03
3.03
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.03
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 3.02
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.0
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 2.98
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 2.96
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.96
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.96
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.95
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.94
Gene expression in GBM with Cav3.2 inhibition 2.85
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 2.83
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.81
Genome-wide functional assessment of enhancer activities in the human genome 2.81
LncRNA expression profiling of ischemic stroke patients 2.79
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.78
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.78
CD73 knockdown effect in pancreatic cancer cell lines 2.73
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 2.72
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 2.72
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.72
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.72
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.71
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 2.68
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.67
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.67
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.64
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.63
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 2.6
iPSC-Derived Cholangiocytes 2.58
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.57
PNET animal model: new insights (II) 2.56
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.56
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.54
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.52
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 2.52
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 2.51
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 2.51
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.45
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 2.45
Targeted enhancer activation by a subunit of the integrator complex 2.42
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.41
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 2.41
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.41
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 2.4
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.39
Gene expression profile of human iPSC-derived nephron progenitor cells 2.39
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.39
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.37
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.36
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.36
quanTIseq: quantifying immune contexture of human tumors 2.33
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 2.33
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.32
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 2.32
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.32
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 2.3
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.29
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.25
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 2.23
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.22
Transcriptome analysis of U87 cells upon LINC00152 knockdown 2.21
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 2.18
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.17
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.15
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 2.14
The comparison of high-throughput single-cell RNA-seq methods 2.14
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.13
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.11
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.09
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.08
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.08
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 2.08
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.07
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.07
RNA-seq analysis of BAP1-depleted uveal melanoma cells 2.06
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.05
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.05
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2.03
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.03
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.02
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 2.01
Gene expressions of H9s in different culture systems 2.0
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.0
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 1.98
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.96
RNA-seq of naive and primed ES cells (NHSM) 1.96
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 1.93
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.91
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.91
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.88
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.88
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 1.88
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.87
1.87
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.87
Gene expression analysis of breast cancer cell-lines 1.87
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.86
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.85
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.85
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.84
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.83
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.83
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.82
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.82
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.82
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.8
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.77
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.74
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.73
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.72
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.7
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.7
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.68
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 1.66
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 1.65
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 1.64
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 1.64
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.64
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 1.62
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.61
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.6
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.6
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.57
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.57
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.56
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.55
AR-independent prostate cancer is sustained through FGF signaling 1.54
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.53
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.52
The conserved transcriptional landscapes in human spermatogenesis 1.52
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.52
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.51
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.51
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 1.51
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.51
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.51
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.48
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 1.47
Human embryonic stem cells in E8 and AKIT culture medium 1.47
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 1.46
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.46
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.46
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 1.46
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 1.46
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.46
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.46
HEK293 Heat-shock experiment 1.46
Dysregulated immune system networks in war veterans with PTSD 1.46
HNRNPL and its RNA Targets in Prostate Cancer 1.45
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 1.45
STX4 Over-Expression in Human islets 1.43
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.42
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.42
Microglia innatly develop within cerebral organoids 1.42
Paxillin regulates genomic networks in prostate cancer [PC3] 1.41
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.41
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.41
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 1.41
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 1.41
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.4
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.4
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.4
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.38
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.38
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.37
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.37
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.37
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.37
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.37
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.36
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 1.36
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 1.35
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 1.32
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.32
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.31
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.31
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.29
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.29
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.29
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.27
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.26
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.25
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.25
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.24
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.23
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.23
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.22
RNA-seq data 1.22
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.21
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.21
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.19
Neonatal and adult human testis defined at the single-cell level 1.19
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 1.17
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.16
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.16
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.16
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.16
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.16
RNA-Seq in PWS iPSC-derived neurons 1.15
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.15
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.15
Multiple sclerosis and EAE 1.15
Human optic chiasm from healthy controls and multiple sclerosis patients 1.15
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.13
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.12
Preclinical model of obesity and ER-positive breast cancer 1.12
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.11
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.11
Transcriptome of EBV-infected gastric cancer cell lines 1.11
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.11
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.1
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.09
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 1.09
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.08
Noncoding regions are the main source of targetable tumor-specific antigens 1.08
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.07
RNA Sequencing of three pairs of gastric cancer 1.06
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 1.05
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.05
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.04
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.04
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.04
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.03
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.03
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.01
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.0
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.0
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.98
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.98
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.97
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.97
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.95
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.95
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.95
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.94
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.94
An optimization system for isolating and sequencing of single human colon cancer cells 0.92
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 0.91
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.91
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 0.91
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 0.91
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.91
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.9
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.89
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.88
Energy Metabolism during Anchorage-Independence 0.87
Downregulation of DDX5/DDX17 and REST 0.87
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.86
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.86
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.86
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.85
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.84
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.84
Role of COP1 on MAP kinase transcriptional output in melanoma 0.84
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.84
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.84
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.83
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.83
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.83
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.83
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.82
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.82
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.81
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.81
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.81
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.8
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.8
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.79
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 0.79
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.78
Measure transcript integrity using RNA-seq data 0.76
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 0.76
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.75
Investigate A2M treatment on human prostate cancer xenograft in mice 0.75
Investigate A2M treatment on human prostate cancer and mouse liver 0.75
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.75
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.74
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.73
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 0.72
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.71
Evaluating pre-clinical models for studying NASH driven HCC. 0.7
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.69
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.68
Deep RNA sequencing of the human placental transcriptome 0.67
Bone marrow derived human B cells [normal proB] 0.67
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.66
Transcriptomic analysis of human macrophages in 3D 0.66
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.65
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.65
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.65
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.64
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.63
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.63
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.63
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.6
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.6
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 0.6
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 0.6
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.6
Differential gene expression profiles in imatinib-resistant cell lines 0.59
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.58
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.57
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.57
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.57
Global transcriptome analysis of WT versus HEB-/- hESCs 0.55
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.55
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.54
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.54
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.54
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.54
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.54
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.54
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.52
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.52
Function and hormonal regulation of GATA3 in human first trimester placentation 0.52
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.51
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.51
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.51
HNRNPM-regulated splicing dependencies in prostate cancer 0.5
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.5
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.49
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.49
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.49
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.49
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 0.49
Epigenomic conservation of transposable element silencing 0.48
Epigenomic conservation of transposable element silencing [RNA-seq] 0.48
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.47
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.47
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 0.47
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.45
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.45
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.45
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.45
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.45
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.43
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.42
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.41
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.41
Landscape of H3K4me3 in human CD19 cells 0.4
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.4
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.39
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.38
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.38
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.38
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.36
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.35
RNA-seq of SCLC PDX models treated with EP 0.33
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 0.33
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.33
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.32
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.32
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.29
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.29
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.29
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.28
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.28
naive T cell heterogeneity after neonatal thymectomy 0.27
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.27
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.26
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.25
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.25
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.24
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.24
RNA-sequencing 0.24
The role of the Calcium-Sensing receptor in colorectal cancer 0.23
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.23
Tpl-2 and MEK small molecule inhibitors 0.23
Tpl-2 small molecule project 0.23
Human ovarian granulosa cell transcriptome 0.22
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.21
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.19
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.19
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.19
Human islets of varying quality: the good, the (not so) bad and the ugly 0.18
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.18
Gene expression analysis upon mtDNA depletion 0.18
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.17
iPSC derived motor neuron cultures from C9ORF72 carriers 0.16
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.16
U2AF1 mutations alter splice site recognition in hematological malignancies 0.16
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.15
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.15
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.13
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.13
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 0.1
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.09
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.09
LIN28A Over-expression RNAseq 0.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.08
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.08
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.08
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.07
The role of m6A/m-RNA methylation in stress response regulation 0.06
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.06
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.05
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.04
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.04
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.04
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.04
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.04
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 0.04
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.04
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 0.03
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.03
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.03
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.03
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.03
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.02
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.02
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.02
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 0.01
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.01
Downregulation of LATS kinases alters p53 to promote cell migration 0.01
Gene expression profiling in metabolically heterogeneous human lung tumors 0.01
Characterization of human ILC2 subsets 0.0
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.0
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation